Elective Coronary Angiography and Anxiety Study

Anxiety Clinical Trial

— ANGST  

Official title:

Evaluating and Predicting Anxiety in Patients Undergoing Elective Coronary Angiography

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02804009
• Other study ID #: GenealTHC
• Status: Recruiting
• Phase: N/A
• First received: June 9, 2016
• Last updated: August 8, 2016
• Start date: November 2015
• Est. completion date: December 2017

Study information

• Verified date: June 2016
• Source: General and Teaching Hospital Celje
• Contact: Anja Kokalj, MD
• Email: anja.kokalj[@]psih-klinika.si
• Is FDA regulated: No
• Health authority: Slovenia: Ethics Committee
• Study type: Observational

Clinical Trial Summary

Anxiety will be assessed from two aspects, the somatic and emotional. ANGST aims to determine how anxiety correlates with psychological parameters (personality traits, coping strategies and depressive symptoms) and with the outcome of elective coronary angiography (CA).

Description:

This research is a prospective cross-section study of patients undergoing elective CA. Research design will allow studying anxiety at four timepoints and its correlation with CA outcome and psychological parameters. This study will be conducted at the Coronary care unit of the department of Cardiology, General and Teaching Hospital Celje, Slovenia.

Data regarding prior to CA, during hospital stay and after discharge variables will be collected in order to control for confounding variables when testing the association between anxiety and psychological parameters. All the data needed for this study will be collected within one month from the patient enrollment in this study at four occasions: (1) 14 days prior CA - all patients will receive questionnaires by post, (2) on the day of the admission, 2-4 hours before CA, (3) 24 hours after CA, but prior to discharge and (4) 4-6 weeks after discharge. Clinical and demographical data will be collected from medical records. Data regarding anxiety and other psychological parameters will be assessed using standardized questionnaires. These will be sent to the patient together with covering letter providing instructions to complete the questionnaires 14 days prior CA without help of family members/friends. A month after CA, the questionnaires for anxiety and depressive symptoms will be sent to participants address with reply paid envelope provided.

The Republic of Slovenia National Medical Ethics Committee has approved this study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 350
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• invited to elective CA because of suspected/unknown: coronary artery disease, valvular heart disease, heart failure etiology, unexplained arrhythmia, cardiomyopathy etiology;

• written consent;

• completed first set of questionnaires 14 days prior to coronary angiography

Exclusion Criteria:

• need for an urgent coronary angiography,

• coronary angiography in last 6 months,

• unable to provide written consent,

• severe physical and/or mental disease/disability,

• help needed in completing the questionnaires,

• unsigned consent form,

• incomplete first set of questionnaires 14 days prior to coronary angiography.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders

Locations

Country	Name	City	State
Slovenia	General and Teaching Hospital Celje	Celje

Sponsors (2)

Lead Sponsor	Collaborator
General and Teaching Hospital Celje	University Psychiatric Clinic Ljubljana

Country where clinical trial is conducted

Slovenia, 

References & Publications (9)

Astin F, Jones K, Thompson DR. Prevalence and patterns of anxiety and depression in patients undergoing elective percutaneous transluminal coronary angioplasty. Heart Lung. 2005 Nov-Dec;34(6):393-401. — View Citation

Chaudhury S, Srivastava K. Relation of depression, anxiety, and quality of life with outcome after percutaneous transluminal coronary angioplasty. ScientificWorldJournal. 2013 Nov 10;2013:465979. doi: 10.1155/2013/465979. eCollection 2013. — View Citation

Damen NL, Versteeg H, Boersma E, de Jaegere PP, van Geuns RJ, van Domburg RT, Pedersen SS. Indication for percutaneous coronary intervention is not associated with symptoms of anxiety and depression. Int J Cardiol. 2013 Oct 12;168(5):4897-8. doi: 10.1016/j.ijcard.2013.07.022. Epub 2013 Jul 19. — View Citation

Pedersen SS, Denollet J, Spindler H, Ong AT, Serruys PW, Erdman RA, van Domburg RT. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention. J Psychosom Res. 2006 Dec;61(6):783-9. — View Citation

Trotter R, Gallagher R, Donoghue J. Anxiety in patients undergoing percutaneous coronary interventions. Heart Lung. 2011 May-Jun;40(3):185-92. doi: 10.1016/j.hrtlng.2010.05.054. Epub 2010 Aug 17. — View Citation

Tully PJ, Cosh SM, Baumeister H. The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res. 2014 Dec;77(6):439-48. doi: 10.1016/j.jpsychores.2014.10.001. Epub 2014 Oct 14. Review. — View Citation

van den Berge JC, Utens EM, Dulfer K, Hartman EM, van Geuns RJ, Daemen J, van Domburg RT. Can anxiety and depression, separately or in combination predict subjective health status 10 years post-PCI? Int J Cardiol. 2015;186:57-9. doi: 10.1016/j.ijcard.2015.03.147. Epub 2015 Mar 17. — View Citation

van Gestel YR, Pedersen SS, van de Sande M, de Jaegere PP, Serruys PW, Erdman RA, van Domburg RT. Type-D personality and depressive symptoms predict anxiety 12 months post-percutaneous coronary intervention. J Affect Disord. 2007 Nov;103(1-3):197-203. Epub 2007 Mar 7. — View Citation

Vogelzangs N, Seldenrijk A, Beekman AT, van Hout HP, de Jonge P, Penninx BW. Cardiovascular disease in persons with depressive and anxiety disorders. J Affect Disord. 2010 Sep;125(1-3):241-8. doi: 10.1016/j.jad.2010.02.112. Epub 2010 Mar 12. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change between emotional anxiety in patients without depressive symptoms	Measured with Spielberger State Anxiety Inventory	Baseline, 2 hours before CA, 24h after CA and 1 month after CA	No
Primary	Change between somatic anxiety in patients without depressive symptoms	Measured with Beck Anxiety Inventory	Baseline, 2 hours before CA, 24h after CA and 1 month after CA	No
Secondary	Depressive symptoms	Measured with Cardiac Depression Scale	Baseline, 1 month after CA	No
Secondary	Personality traits	Measured with 10-item short version of Big Five Inventory	Baseline	No
Secondary	Response on stress	Measured with COPE Inventory	Baseline	No
Secondary	Trait Anxiety	Measured with Spielberger Trait Anxiety Inventory	Baseline	No